Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Replimune Group Inc shares valued at $49,157 were sold by Hill Emily Luisa on Aug 15 ’25. At $5.37 per share, Hill Emily Luisa sold 9,154 shares. The insider’s holdings dropped to 134,368 shares worth approximately $0.72 million following the completion of this transaction.
Also, Astley-Sparke Philip sold 32,279 shares, netting a total of over 260,169 in proceeds. Following the sale of shares at $8.06 each, the insider now holds 1,405,071 shares.
Before that, Xynos Konstantinos had sold 7,952 shares from its account. In a trade valued at $64,093, the Chief Medical Officer traded Replimune Group Inc shares for $8.06 each. Upon closing the transaction, the insider’s holdings decreased to 7,952 shares, worth approximately $0.79 million.
As published in a research note from Cantor Fitzgerald on July 30, 2025, Replimune Group Inc [REPL] has been rated up from a Neutral to an Overweight. Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late July. As of July 23, 2025, BMO Capital Markets has decreased its “an Outperform” rating to a “an Underperform” for REPL. Earlier on July 23, 2025, Barclays downgraded its rating. Their new recommendation was “an Equal weight” for REPL stock which previously was a “an Overweight”.
Analyzing REPL Stock Performance
On last trading session, Replimune Group Inc [NASDAQ: REPL] plunged -2.71% to $5.38. The stock’s lowest price that day was $5.37, but it reached a high of $5.66 in the same session. During the last five days, there has been a drop of approximately -3.93%. Over the course of the year, Replimune Group Inc shares have dropped approximately -47.72%. Shares of the company reached a 52-week high of $14.80 on 02/21/25 and a 52-week low of $2.68 on 07/22/25.
Support And Resistance Levels for Replimune Group Inc (REPL)
According to the 24-hour chart, there is a support level at 5.28, which, if violated, would cause prices to drop to 5.18. In the upper region, resistance lies at 5.57. The next price resistance is at 5.76. RSI (Relative Strength Index) is 43.83 on the 14-day chart, showing neutral technical sentiment.
Is Replimune Group Inc subject to short interest?
Stocks of Replimune Group Inc saw a sharp rise in short interest on 2025-08-15 jumping by 11.18 million shares to 19.2 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 8.02 million shares. A jump of 58.22% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.91 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.91.
Which companies own the most shares of Replimune Group Inc (REPL)?
In terms of Replimune Group Inc share price expectations, FactSet research, analysts set an average price target of 23 in the next 12 months, up nearly 315.91% from the previous closing price of $5.53. Analysts anticipate Replimune Group Inc stock to reach 43 by 2025, with the lowest price target being 13. In spite of this, 5 analysts ranked Replimune Group Inc stock as Buy at the end of 2025. On July 22, 2025, Wedbush assigned a price target of “a Neutral” to the stock and downgraded coverage with a $4.
